ARTICLE | Finance
KdT closes new $100M+ fund; portfolio company Terray draws $120M series B
BioCentury’s Venture Report also includes fundings for Nuclera, TenNor, Shift, Tolerance and Sunbird
October 18, 2024 12:45 AM UTC
Early-stage investor KdT Ventures will have more than $100 million in fresh capital to back start-ups across a range of life sciences sectors, including biopharmas.
The Austin and North Carolina-based firm closed its fourth fund just over two years after announcing its $80 million third fund. KdT has invested in 65 companies thus far; about two dozen of its deals have been in the biopharma space, according to BioCentury’s BCIQ database, while others are in the agricultural or chemical sectors...